Volume 20, Number 5—May 2014
Chronic Wasting Disease Agents in Nonhuman Primates
|Disease incidence†||Inoculum‡||Route of inoculation||Titer inoculated§||Screening mpi¶||Current mpi|
|0/6||MD-1, Elk-1, WTD-1||Intracerebral||3.2 × 105–2.5 × 106||49, 79, 88, 94||124|
|0/8#||MD-1, Elk-1, WTD-1||Oral||2.5 × 108–2 × 109||97,106,106||124|
*An early version of some of these data are shown in Table 3 of (7). CWD, chronic wasting disease; mpi, months post-inoculation; MD, mule deer; WTD, white-tailed deer; SM, squirrel monkey; NA, not applicable.
†Number of monkeys in which prion disease developed over number inoculated.
‡Several different inocula were used for this study. Each individual animal was inoculated with 1 inoculum. Detailed descriptions can be found in (7).
§Infectivity titers were determined by using endpoint dilution titer in transgenic mice expressing deer prion protein (PrPres) and are listed as 50% infectious dose per gram of brain.
¶Several monkeys were euthanized during the course of the experiment for conditions unrelated to prion infection such as diabetes, neoplasia, hypocalcemia, and behavioral issues. Brain, spleen, and lymph nodes from these animals were screened for PrPres by using Western blot and immunohistochemical methods. No PrPres-positive tissues were detected.
#One monkey from the original oral inoculation group was euthanized at 1 mpi because of a colonic torsion and has been removed from this group.
- Page created: April 17, 2014
- Page last updated: April 17, 2014
- Page last reviewed: April 17, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)